PureTech Health (PRTC) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Mar 2022 12:05 PM
RNS
Akili Named to World's Most Innovative Companies
18 Feb 2022 04:30 PM
RNS
Holding(s) in Company
17 Feb 2022 12:05 PM
RNS
Akili Data: Enhanced Brain Activity in Kids w/ADHD
15 Feb 2022 07:00 AM
RNS
PRTC's Akili Files Registration Statement on S-4
10 Feb 2022 12:00 PM
RNS
PRTC to Present at Leerink Healthcare Conference
04 Feb 2022 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
31 Jan 2022 11:50 AM
RNS
PRTC's Gelesis Launches Plenity Media Campaign
26 Jan 2022 12:02 PM
RNS
PRTC's Akili to Become Public & $162M Funding
14 Jan 2022 07:00 AM
RNS
PRTC's Gelesis to Debut on NYSE Today Ticker GLS
07 Jan 2022 12:00 PM
RNS
PureTech to Present at JPM Healthcare Conference
06 Jan 2022 07:00 AM
RNS
LYT-100 Shows Improved AE Profile vs Pirfenidone
05 Jan 2022 12:05 PM
RNS
Gelesis Adds to BOD & Declared Effective by SEC
20 Dec 2021 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
16 Dec 2021 07:00 AM
RNS
PRTC Provides Recap Ahead of Catalyst-Rich 2022
08 Dec 2021 12:00 PM
RNS
PRTC Presents Data at ACNP Conference For LYT-300
07 Dec 2021 12:00 PM
RNS
PRTC's Lymphatic Platform Candidate Human Study
01 Dec 2021 12:10 PM
RNS
PRTC: Gelesis' Plenity Now Broadly Available in US
01 Dec 2021 07:00 AM
RNS
Total Voting Rights
18 Nov 2021 12:10 PM
RNS
PRTC's Gelesis Receives $30M Plenity Order from Ro
16 Nov 2021 12:00 PM
RNS
PRTC Publishes Previous LYT-100 MAD Study Results
15 Nov 2021 12:00 PM
RNS
PRTC Presents at Two Upcoming Investor Conferences
12 Nov 2021 12:00 PM
RNS
PRTC Presents Immunooncology Ph 1/2 Trial at SITC
11 Nov 2021 12:00 PM
RNS
FDA Grants PRTC's LYT-200 Orphan Drug Designation
10 Nov 2021 07:00 AM
RNS
PRTC Receives $100M from Founded Entity Shares
09 Nov 2021 12:34 PM
RNS
KRTX and Zai Lab to Develop KarXT in Greater China
09 Nov 2021 07:00 AM
RNS
PRTC Presents at Jefferies Healthcare Conference
01 Nov 2021 10:20 AM
RNS
New Research in Journal Nature on Gelesis Tech
01 Nov 2021 07:00 AM
RNS
Total Voting Rights
22 Oct 2021 06:00 PM
RNS
Holdings in Company - TR-1 Correction Announcement
20 Oct 2021 04:35 PM
RNS
Price Monitoring Extension
14 Oct 2021 12:01 PM
RNS
PRTC's Vedanta Appoints Chief Legal Officer
12 Oct 2021 07:00 AM
RNS
Additional Listing
05 Oct 2021 01:01 PM
RNS
Vedanta Positive Phase 2 Data in C. Diff Infection
05 Oct 2021 01:00 PM
RNS
PRTC's Sonde Launches Mental Health Monitor
29 Sep 2021 01:01 PM
RNS
Akili/Shionogi Report Positive Ph2 Data in Japan
20 Sep 2021 04:02 PM
RNS
New PureTech Research Published In Nature Journal
14 Sep 2021 12:00 PM
RNS
PRTC to Present at Oppenheimer Healthcare Summit
10 Sep 2021 07:00 AM
RNS
PRTC's Vor Granted FDA Fast Track Designation
01 Sep 2021 07:00 AM
RNS
Total Voting Rights
24 Aug 2021 07:00 AM
RNS
Half-year Report
23 Aug 2021 12:00 PM
RNS
PRTC Presents LYT-100 Ph1 PK & Tolerability at ERS
17 Aug 2021 01:03 PM
RNS
Akili Deal Furthers Digital Medicine Leadership
13 Aug 2021 12:00 PM
RNS
PRTC Appoints Industry Veteran & Physician as CMO
11 Aug 2021 12:00 PM
RNS
PRTC Receives $6.5M; Imbrium to Develop LYT-503
03 Aug 2021 07:00 AM
RNS
Notice of Results
02 Aug 2021 07:00 AM
RNS
Total Voting Rights
23 Jul 2021 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
22 Jul 2021 01:03 PM
RNS
PRTC's Akili Releases New Features for EndeavorRx
22 Jul 2021 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
21 Jul 2021 12:03 PM
RNS
PureTech's Vedanta Raises $68M Series D Financing

PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange under the ticker PRTC.

PureTech share price launched at 178p in 2015.

UK 100